Washed Microbiota Transplantation for Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes Interventions: Other: WMT Sponsors: The Second Hospital of Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Conditions: Liver Transplant; Hepatocellular Carcinoma Recurrent; Systemic Treatment Interventions: Drug: Systemic therapy Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation
Conditions: Graft Versus Host Disease; Hematologic Malignancy Interventions: Drug: Methotrexate; Drug: Post-Transplant Cyclophosphamide; Drug: Fludarabine; Drug: Cycophosphamide; Drug: Anti-Thymoglobulin; Radiation: total body irradiation; Other: hematopoietic stem cells; Other: Graft nuclear cells; Other: Donor Lymphocytes Injection; Drug: Clofarabine; Drug: Thiotepa; Drug: Busulfan; Drug: Fludarabine Sponsors: Nantes University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Fecal Transplantation in Patients Colonic Diverticulitis
Conditions: Diverticulitis, Colonic; Colon Inflamed Interventions: Other: Fecal Microbiome; Other: Placebo Sponsors: Odense University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Impact of the Ex-vivo Pulmonary Perfusion System on the Microbiome of Lung Grafts and Their Inflammatory Reaction.
Conditions: Lung Transplant Failure Interventions: Device: EVLP; Device: Cold preservation Sponsors: Vall d ' Hebron Institute Research; Hospital Clinic of Barcelona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Weight Loss and Physical Activity Lifestyle Interventions In Post Liver And Kidney Transplants
Conditions: Weight Loss; Lifestyle Factors Interventions: Device: Wrist activity tracker and scale; Behavioral: Nutritional Coaching group sessions Sponsors: Massachusetts General Hospital; American Society of Transplantation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Whole-Body Electrical Stimulation in Patients Undergoing Lung Transplantation
Conditions: Lung Transplantation; Electric Stimulation Interventions: Other: Whole-body electrical stimulation; Other: Routine physical therapy Sponsors: Federal University of Health Science of Porto Alegre; Irmandade Santa Casa de Miseric órdia de Porto Alegre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Emdogain Adjunctive to Autotransplantation
Conditions: Autotransplantation; Emdogain; Autologous Transplantation; Enamel Matrix Derivatives Interventions: Biological: Emdogain (EMD) - test; Procedure: Sham group Sponsors: Universidad Complutense de Madrid Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
Conditions: Very High Risk Acute Lymphoblastic Leukemia; CD19 CAR-T Therapy Interventions: Genetic: SNUH-CD19-CAR-T Sponsors: Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)
Conditions: Chronic Graft Versus Host Disease Interventions: Biological: Additional blood sample; Biological: cGVHD target tissue biopsy Sponsors: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Improving KIdney Transplantation With Cellular Therapy Study
Conditions: Immune Tolerance; Kidney Transplant Rejection Interventions: Other: Tolerance induction Sponsors: Western Sydney Local Health District Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Conditions: Cytomegalovirus (CMV); Kidney Disease; Kidney Failure Interventions: Other: No Intervention Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Brain Abscesses in Transplant Recipients: a Multicentre Retrospective Study (BAT-STUDY)
Conditions: Brain Abscess Interventions: Other: Retrospective follow-up Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT
Conditions: Moxibustion; Hematopoietic Stem Cell Transplantation; Hemorrhagic Cystitis; Treatment Interventions: Other: Moxibustion; Other: Symptomatic supportive treatment Sponsors: Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Comparison Of Efficacy And Safety Of Thalidomide Vs Hydroxyurea In Thalassemia Patients: A Single-Centre Pilot Study.
Conditions: Beta-Thalassemia Interventions: Drug: Thalidomide 100mg; Drug: Hydroxyurea Sponsors: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
